GB2045745B - Intermediates for prostaglandin analogues - Google Patents

Intermediates for prostaglandin analogues

Info

Publication number
GB2045745B
GB2045745B GB8002207A GB8002207A GB2045745B GB 2045745 B GB2045745 B GB 2045745B GB 8002207 A GB8002207 A GB 8002207A GB 8002207 A GB8002207 A GB 8002207A GB 2045745 B GB2045745 B GB 2045745B
Authority
GB
United Kingdom
Prior art keywords
intermediates
prostaglandin analogues
prostaglandin
analogues
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB8002207A
Other languages
English (en)
Other versions
GB2045745A (en
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ono Pharmaceutical Co Ltd
Original Assignee
Ono Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP655779A external-priority patent/JPS55100379A/ja
Priority claimed from JP655679A external-priority patent/JPS55100378A/ja
Priority claimed from JP655579A external-priority patent/JPS55100377A/ja
Application filed by Ono Pharmaceutical Co Ltd filed Critical Ono Pharmaceutical Co Ltd
Publication of GB2045745A publication Critical patent/GB2045745A/en
Application granted granted Critical
Publication of GB2045745B publication Critical patent/GB2045745B/en
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D309/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/02Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D309/08Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D309/10Oxygen atoms
    • C07D309/12Oxygen atoms only hydrogen atoms and one oxygen atom directly attached to ring carbon atoms, e.g. tetrahydropyranyl ethers
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C405/00Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C405/00Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
    • C07C405/0008Analogues having the carboxyl group in the side-chains replaced by other functional groups
    • C07C405/0016Analogues having the carboxyl group in the side-chains replaced by other functional groups containing only hydroxy, etherified or esterified hydroxy groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C405/00Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
    • C07C405/0008Analogues having the carboxyl group in the side-chains replaced by other functional groups
    • C07C405/0025Analogues having the carboxyl group in the side-chains replaced by other functional groups containing keto groups
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
GB8002207A 1979-01-25 1980-01-23 Intermediates for prostaglandin analogues Expired GB2045745B (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP655779A JPS55100379A (en) 1979-01-25 1979-01-25 Preparation of prostaglandin analog and its intermediate
JP655679A JPS55100378A (en) 1979-01-25 1979-01-25 Intermediate for prostaglandin analog and its preparation
JP655579A JPS55100377A (en) 1979-01-25 1979-01-25 Intermediate for prostaglandim analog and its preparation

Publications (2)

Publication Number Publication Date
GB2045745A GB2045745A (en) 1980-11-05
GB2045745B true GB2045745B (en) 1983-08-17

Family

ID=27277218

Family Applications (1)

Application Number Title Priority Date Filing Date
GB8002207A Expired GB2045745B (en) 1979-01-25 1980-01-23 Intermediates for prostaglandin analogues

Country Status (9)

Country Link
CA (1) CA1154441A (US07968547-20110628-C00004.png)
CH (1) CH644360A5 (US07968547-20110628-C00004.png)
DK (1) DK165111C (US07968547-20110628-C00004.png)
FR (1) FR2447374A1 (US07968547-20110628-C00004.png)
GB (1) GB2045745B (US07968547-20110628-C00004.png)
HU (1) HU183068B (US07968547-20110628-C00004.png)
IT (1) IT1149877B (US07968547-20110628-C00004.png)
NL (1) NL8000428A (US07968547-20110628-C00004.png)
SE (1) SE452157B (US07968547-20110628-C00004.png)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1540427A (en) * 1972-12-29 1979-02-14 Ono Pharmaceutical Co Prostaglandin analogues
US3931296A (en) * 1972-12-29 1976-01-06 Masaki Hayashi Trans-Δ2 -prostaglandins

Also Published As

Publication number Publication date
NL8000428A (nl) 1980-07-29
FR2447374A1 (fr) 1980-08-22
HU183068B (en) 1984-04-28
GB2045745A (en) 1980-11-05
CA1154441A (en) 1983-09-27
IT8019399A0 (it) 1980-01-23
FR2447374B1 (US07968547-20110628-C00004.png) 1981-12-11
SE8000545L (sv) 1980-07-26
IT1149877B (it) 1986-12-10
DK165111C (da) 1993-03-01
CH644360A5 (fr) 1984-07-31
DK165111B (da) 1992-10-12
DK27780A (da) 1980-07-26
SE452157B (sv) 1987-11-16

Similar Documents

Publication Publication Date Title
GB2137611B (en) Prostaglandin intermediates
ZA783065B (en) Prostaglandin analogs
GB2006753B (en) Prostaglandin analogues
GB2006754A (en) Prostaglandin 1 analogues
GB2041368B (en) Prostaglandin analogues
GB2053223B (en) Prostaglandin intermediates
PT69749A (en) Prostaglandin analogues
IL56814A0 (en) Prostaglandin analogs
ZA781608B (en) Prostaglandin analogs
IL61099A0 (en) Prostacyclin analogues
GB2002355B (en) Prostaglandin analogues
GB2045745B (en) Intermediates for prostaglandin analogues
IL52685A0 (en) Intermediates for cephalosporin analogues
JPS55149246A (en) Prostaglandin e1 derivative
ZA791296B (en) Prostaglandin analogs
JPS5686150A (en) Novel prostaglandin derivative
IE791140L (en) Prostaglandin analogues
IE791139L (en) Prostaglandin analogues
AU512960B2 (en) Exo-amide prostaglandin analogues
AU494158B2 (en) Intermediates for prostaglandin analogs
ZA805820B (en) Prostacyclin analogues
DE3175361D1 (en) Prostaglandin intermediates
ZA776365B (en) Exo-amide prostaglandin analogues
IE832160L (en) Prostaglandin analogues
IE780131L (en) Prostaglandin analogs

Legal Events

Date Code Title Description
PE20 Patent expired after termination of 20 years

Effective date: 20000122